A Randomised Trial of Paclitaxel (Taxol) in Combination with Platinum Chemotherapy versus Conventional Platinum-Based Chemotherapy in the Treatment of Women with Relapsed Ovarian Cancer.

Trial Profile

A Randomised Trial of Paclitaxel (Taxol) in Combination with Platinum Chemotherapy versus Conventional Platinum-Based Chemotherapy in the Treatment of Women with Relapsed Ovarian Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Paclitaxel (Primary) ; Carboplatin; Cisplatin
  • Indications Ovarian cancer; Peritoneal cancer
  • Focus Therapeutic Use
  • Acronyms ICON-4
  • Most Recent Events

    • 08 Dec 2015 Accrual to date is 8%, according to United Kingdom Clinical Research Network record.
    • 03 Jul 2009 Additional lead trial investigator (Amos C) identified as reported by ClinicalTrials.gov.
    • 03 Jul 2009 New source identified and integrated (ISRCTN: Current Controlled Trials).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top